298 related articles for article (PubMed ID: 11751390)
21. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
[TBL] [Abstract][Full Text] [Related]
22. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
Jeon HS; Kim KM; Park SH; Lee SY; Choi JE; Lee GY; Kam S; Park RW; Kim IS; Kim CH; Jung TH; Park JY
Carcinogenesis; 2003 Oct; 24(10):1677-81. PubMed ID: 12869423
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women.
Lee SA; Kim JW; Roh JW; Choi JY; Lee KM; Yoo KY; Song YS; Kang D
Gynecol Oncol; 2004 Apr; 93(1):14-8. PubMed ID: 15047208
[TBL] [Abstract][Full Text] [Related]
24. Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma.
El-Zein RA; Zwischenberger JB; Abdel-Rahman SZ; Sankar AB; Au WW
Cancer Lett; 1997 Jan; 112(1):71-8. PubMed ID: 9029171
[TBL] [Abstract][Full Text] [Related]
25. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma.
Peters ES; McClean MD; Marsit CJ; Luckett B; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2196-202. PubMed ID: 17119046
[TBL] [Abstract][Full Text] [Related]
26. Lack of interaction between asbestos exposure and glutathione S-transferase M1 and T1 genotypes in lung carcinogenesis.
Stücker I; Boffetta P; Antilla S; Benhamou S; Hirvonen A; London S; Taioli E
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1253-8. PubMed ID: 11751442
[TBL] [Abstract][Full Text] [Related]
27. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer.
Goto I; Yoneda S; Yamamoto M; Kawajiri K
Cancer Res; 1996 Aug; 56(16):3725-30. PubMed ID: 8706015
[TBL] [Abstract][Full Text] [Related]
29. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.
Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M
Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853
[TBL] [Abstract][Full Text] [Related]
31. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
32. Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition.
Reszka E; Wasowicz W; Rydzynski K; Szeszenia-Dabrowska N; Szymczak W
Neoplasma; 2003; 50(5):357-62. PubMed ID: 14628089
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
[TBL] [Abstract][Full Text] [Related]
34. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
Xing DY; Qi J; Tan W; Miao XP; Liang G; Yu CY; Lu WF; Zhou CN; Wu M; Lin DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):35-8. PubMed ID: 12579497
[TBL] [Abstract][Full Text] [Related]
35. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
36. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
37. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer.
Bendesky A; Rosales A; Salazar AM; Sordo M; Peniche J; Ostrosky-Wegman P
Mutat Res; 2007 Jun; 619(1-2):38-44. PubMed ID: 17403527
[TBL] [Abstract][Full Text] [Related]
38. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
39. GSTM1 and codon 72 P53 polymorphism in multiple myeloma.
Ortega MM; Honma HN; Zambon L; Lorand-Metze I; Costa FF; De Souza CA; Lima CS
Ann Hematol; 2007 Nov; 86(11):815-9. PubMed ID: 17653713
[TBL] [Abstract][Full Text] [Related]
40. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
